Prevalence of Depression and Use of Antidepressant Pharmacotherapy Among Ambulatory Patients With Diabetes Mellitus in the United States

被引：1

作者：

Neumiller, Joshua J. ^{[1
]}

Sclar, David A. ^{[2
]}

Robison, Linda M. ^{[3
]}

Setter, Stephen M. ^{[1
]}

Skaer, Tracy L. ^{[2
]}

机构：

[1] Washington State Univ, Dept Pharmacotherapy, Coll Pharm, Spokane, WA 99210 USA

[2] Washington State Univ, Coll Pharm, Dept Pharmacotherapy, Dept Hlth Policy & Adm, Pullman, WA 99164 USA

[3] Washington State Univ, Dept Hlth Policy & Adm, Coll Pharm, Pullman, WA 99164 USA

来源：

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 2009年 / 70卷 / 06期

关键词：

depression; diabetes mellitus; antidepressant pharmacotherapy; DIAGNOSIS; BURDEN; IMPACT;

D O I：

10.1016/j.curtheres.2009.12.001

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

BACKGROUND: Persons with diabetes mellitus (DM) exhibit a higher rate of depressive illness than does the general US population. Despite this finding, previous research has documented a low rate of diagnosis and/or treatment with antidepressant pharmacotherapy among persons with DM. OBJECTIVE: The aim of this study was to examine the Current rate of diagnosis of depression and use of antidepressant pharmacotherapy among persons with DM. RESULTS: We examined data from the 2005 US National Ambulatory Medical Care Survey. In 2005, there were an estimated 35,345,845 persons with an office-based visit for DM and, of these, 3,823,508 (10.8%) had a concomitant diagnosis of depression. Within this subset, 1,830,620 (47.9%) were prescribed antidepressant pharmacotherapy. CONCLUSION: Our findings serve to quantify the prevalence of a diagnosis of depression and use of antidepressant pharmacotherapy for its treatment among persons with DM in the United States. (Curr Ther Res Clin Exp. 2009;70:472-476) (C) 2009 Excerpta Medica Inc.

引用

页码：472 / 476

页数：5

共 12 条

[1]

[Anonymous], 2002, DIABETES CARE, V26, P917

[2] Projection of diabetes burden through 2050 - Impact of changing demography and disease prevalence in the US [J].

Boyle, JP ;

Honeycutt, AA ;

Narayan, KMV ;

Hoerger, TJ ;

Geiss, LS ;

Chen, H ;

Thompson, TJ .

DIABETES CARE, 2001, 24 (11) :1936-1940

[3]

Center for Disease Control and Prevention, Ambulatory health care data

[4] Healthy coping, negative emotions, and diabetes management - A systematic review and appraisal [J].

Fisher, Edwin B. ;

Thorpe, Carolyn T. ;

DeVellis, Brenda McEvoy ;

DeVellis, Robert F. .

DIABETES EDUCATOR, 2007, 33 (06) :1080-1103

[5] Depression in diabetic patients - The relationship between mood and glycemic control [J].

Lustman, PJ ;

Clouse, RE .

JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2005, 19 (02) :113-122

[6] Impact of recent increase in incidence on future diabetes burden - US, 2005-2050 [J].

Narayan, K. M. Venkat ;

Saaddine, Jinan B. ;

Boyle, James P. ;

Thompson, Theodore J. ;

Geiss, Linda S. .

DIABETES CARE, 2006, 29 (09) :2114-2116

[7] Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program [J].

Rubin, Richard R. ;

Ma, Yong ;

Marrero, David G. ;

Peyrot, Mark ;

Barrett-Connor, Elizabeth L. ;

Kahn, Steven E. ;

Haffner, Steven M. ;

Price, David W. ;

Knowler, William C. .

DIABETES CARE, 2008, 31 (03) :420-426

[8] Depression in diabetes mellitus: A national survey of office-based encounters, 1990-1995 [J].

Sclar, DA ;

Robison, LM ;

Skaer, TL ;

Galin, RS .

DIABETES EDUCATOR, 1999, 25 (03) :331-+

[9]

SCLAR DA, 1999, DIABETES ED, V25, P340

[10] Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States [J].

Sclar, David A. ;

Robison, Linda M. ;

Skaer, Tracy L. .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (02) :106-109

← 1 2 →